BU-NOT-SET

CONTACT US
Successful drug development
  • Drug product
Eyes
Insight
How CDMOs can help reduce the risk of counterfeit medicines entering the supply chain
  • Manufacturing
Eyes
Insight
Tackling complexity in scale-up
  • Drug product
Lab equipment
Insight
Navigating COVID-19 – the role of CDMOs
  • Industry trends
Eyes
Insight
Best pharmaceutical dosage forms
  • Drug product
Production line
Insight
Taking an innovative approach to analytical chemistry
  • Analytical chemistry
Eyes
Insight
Recipharm and Oncopeptides collaborate in the development of Melflufen for the treatment of multiple myeloma
  • Analytical chemistry
Eyes
Insight
Excipients for orally disintegrating products
  • Drug product
Eyes
Insight
Recipharm increases API and raw material stocks to ensure supply amid higher antibiotics demand
  • Drug substance
Eyes
Insight
Insight
  • Biologics
ReciBioPharm Is Advancing xRNA Production
eBook
  • Drug product
  • Manufacturing
Navigating the complexities of pre-filled syringes for biologics
Insight
  • Drug product
  • Manufacturing
Unlocking the potential of mRNA with robust lyophilisation strategies
Insight
  • Biologics
Advanced Bio Is Advancing AAV Production
Insight
  • Biologics
Advanced is advancing xRNA manufacturing
Insight
  • Drug product
  • Manufacturing
What are the innovations driving the future of sterile drug packaging?
Insight
  • Biologics
Revolutionising gene editing with end-to-end CDMO services
Insight
  • Biologics
Advanced Bio streamlines regulatory compliance
Insight
  • Biologics
Advanced Bio leads nucleic acid innovation